&nbsp;

treemapDesignPage3.html

Apr 2022

Regimen

TRAM

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

trametinib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

TAFA(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Drugs Used:

tafasitamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

TRAS(MNT)

Cancer Type:

Head and Neck,

Salivary Gland

Intent: Palliative

Drugs Used:

trastuzumab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2022

Drug

thiotepa

Other Name(s): Tepadina®

Quick Link(s): Drug Monograph

Jan 2023

Regimen

TECL; TECL(RAMP)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

teclistamab (Compassionate)

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

TRIFTIPI+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

Exceptional Access Program

trifluridine / tipiracil - In combination with bevacizumab for treatment of metastatic colorectal cancer, according to clinical criteria

New Drug Funding Program

Bevacizumab (Biosimilar) - In Combination with Trifluridine and Tipiracil for Previously Treated Metastatic Colorectal Cancer

trifluridine / tipiracil,

Drugs Used:

bevacizumab

Quick Link(s):

Regimen Monograph

Nov 2024

Document

YVM-Postcard-Print-English.pdf

Nov 2023

Document

YVM-Postcard-Print-French.pdf

Nov 2023

Document

YVM-Postcard-Web-English.pdf

Nov 2023

Document